Literature DB >> 12034885

Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.

Joanne Fanelli Panus1, Craig A Smith, Caroline A Ray, Terri Davis Smith, Dhavalkumar D Patel, David J Pickup.   

Abstract

Cowpox virus (Brighton Red strain) possesses one of the largest genomes in the Orthopoxvirus genus. Sequence analysis of a region of the genome that is type-specific for cowpox virus identified a gene, vCD30, encoding a soluble, secreted protein that is the fifth member of the tumor necrosis factor receptor family known to be encoded by cowpox virus. The vCD30 protein contains 110 aa, including a 21-residue signal peptide, a potential O-linked glycosylation site, and a 58-aa sequence sharing 51-59% identity with highly conserved extracellular segments of both mouse and human CD30. A vCD30Fc fusion protein binds CD153 (CD30 ligand) specifically, and it completely inhibits CD153/CD30 interactions. Although the functions of CD30 are not well understood, the existence of vCD30 suggests that the cellular receptor plays a significant role in normal immune responses. Viral inhibition of CD30 also lends support to the potential therapeutic value of targeting CD30 in human inflammatory and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12034885      PMCID: PMC123070          DOI: 10.1073/pnas.122238599

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  81 in total

1.  Recognition and destruction of virus-infected cells by human gamma delta CTL.

Authors:  J F Bukowski; C T Morita; M B Brenner
Journal:  J Immunol       Date:  1994-12-01       Impact factor: 5.422

2.  Further analyses of the orthopoxviruses volepox virus and raccoon poxvirus.

Authors:  J C Knight; C S Goldsmith; A Tamin; R L Regnery; D C Regnery; J J Esposito
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

3.  Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein.

Authors:  M K Spriggs; D E Hruby; C R Maliszewski; D J Pickup; J E Sims; R M Buller; J VanSlyke
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

4.  High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS.

Authors:  G Pizzolo; F Vinante; L Morosato; G Nadali; M Chilosi; G Gandini; A Sinicco; R Raiteri; G Semenzato; H Stein
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

5.  CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF.

Authors:  C A Smith; H J Gruss; T Davis; D Anderson; T Farrah; E Baker; G R Sutherland; C I Brannan; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

6.  Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor.

Authors:  F Q Hu; C A Smith; D J Pickup
Journal:  Virology       Date:  1994-10       Impact factor: 3.616

7.  A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection.

Authors:  A Alcamí; G L Smith
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

8.  Encoding of a homolog of the IFN-gamma receptor by myxoma virus.

Authors:  C Upton; K Mossman; G McFadden
Journal:  Science       Date:  1992-11-20       Impact factor: 47.728

9.  Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis.

Authors:  F Vinante; L Morosato; F Siviero; G Nadali; A Rigo; D Veneri; D de Sabata; C Vincenzi; M Chilosi; G Semenzato
Journal:  Haematologica       Date:  1994 Sep-Oct       Impact factor: 9.941

10.  Cultured human NK cells express the Ki-1/CD30 antigen.

Authors:  A Cambiaggi; C Cantoni; S Marciano; D De Totero; S Pileri; P L Tazzari; H Stein; S Ferrini
Journal:  Br J Haematol       Date:  1993-10       Impact factor: 6.998

View more
  22 in total

Review 1.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30).

Authors:  S C Burgess; J R Young; B J G Baaten; L Hunt; L N J Ross; M S Parcells; P M Kumar; C A Tregaskes; L F Lee; T F Davison
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-08       Impact factor: 11.205

3.  Genome of horsepox virus.

Authors:  E R Tulman; G Delhon; C L Afonso; Z Lu; L Zsak; N T Sandybaev; U Z Kerembekova; V L Zaitsev; G F Kutish; D L Rock
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Comparative Biochemical and Functional Analysis of Viral and Human Secreted Tumor Necrosis Factor (TNF) Decoy Receptors.

Authors:  Sergio M Pontejo; Ali Alejo; Antonio Alcami
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

5.  Cowpox virus inhibits human dendritic cell immune function by nonlethal, nonproductive infection.

Authors:  Spencer J Hansen; John Rushton; Alexander Dekonenko; Hitendra S Chand; Gwyneth K Olson; Julie A Hutt; David Pickup; C Rick Lyons; Mary F Lipscomb
Journal:  Virology       Date:  2011-02-21       Impact factor: 3.616

Review 6.  Mechanisms of immunomodulation by mammalian and viral decoy receptors: insights from structures.

Authors:  Jan Felix; Savvas N Savvides
Journal:  Nat Rev Immunol       Date:  2016-12-28       Impact factor: 53.106

7.  Modified vaccinia virus Ankara can activate NF-kappaB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replication.

Authors:  Heather E Lynch; Caroline A Ray; Katrina L Oie; Justin J Pollara; Ian T D Petty; Anthony J Sadler; Bryan R G Williams; David J Pickup
Journal:  Virology       Date:  2009-09-01       Impact factor: 3.616

Review 8.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

9.  MHC-I-restricted epitopes conserved among variola and other related orthopoxviruses are recognized by T cells 30 years after vaccination.

Authors:  S T Tang; M Wang; K Lamberth; M Harndahl; M H Dziegiel; M H Claesson; S Buus; O Lund
Journal:  Arch Virol       Date:  2008-09-12       Impact factor: 2.574

10.  A survey of host range genes in poxvirus genomes.

Authors:  Kirsten A Bratke; Aoife McLysaght; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2012-12-23       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.